The cloning industry is contracting—ironically, perhaps.

On Tuesday, Colossal Biosciences announced that it has acquired ViaGen Pets and Equine, an animal cloning firm, marking Colossal’s first acquisition since it launched in 2021.

Texas-based Colossal Biosciences is best known for its controversial “de-extinction” endeavors, which involve efforts to recover species that have died out. Earlier this year, the company claimed to have “brought back” dire wolves, an assertion that was disputed by some experts, as the animals were created by modifying the DNA of existing gray wolves.

The company has also sparked debates about the ethics of bringing species back from extinction, or if what it’s doing is in fact “de-extinction” at all.

Either way, Colossal has attracted significant interest

See Full Page